Novartis ٥ مايو ٢٠٢٦ Celcuity’s gedatolisib beats Novartis drug in Phase III test - The Pharma Letter
Novartis ٤ مايو ٢٠٢٦ After March cuts, Novartis trims another 60 roles at US headquarters - Fierce Pharma
Novartis ٤ مايو ٢٠٢٦ Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study - Fierce Biotech
Novartis ٣٠ أبريل ٢٠٢٦ Novartis finalizes US manufacturing and R&D expansion plan - The Pharma Letter
Novartis ٣٠ أبريل ٢٠٢٦ Novartis to build Morrisville pharma facility as part of $23 billion push - CBS 17
Novartis ٣٠ أبريل ٢٠٢٦ Novartis rounds out $23B US investment push with plans for North Carolina API plant - Fierce Pharma
Novartis ٣٠ أبريل ٢٠٢٦ Novartis Reshapes Growth With Biotech Deals And AI Powered R&D Push - Yahoo Finance
Novartis ٢٩ أبريل ٢٠٢٦ Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval - BioSpace
Novartis ٢٨ أبريل ٢٠٢٦ Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies - Fierce Pharma
Novartis ٢٨ أبريل ٢٠٢٦ Novartis’ sales dip as generics pressure intensifies, radioequivalents loom - BioSpace
Novartis ٢٨ أبريل ٢٠٢٦ Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months' - CNBC
Novartis ٢٨ أبريل ٢٠٢٦ Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts, but no deals in the works - Fierce Biotech
Novartis ٢٧ أبريل ٢٠٢٦ Biopharma bites: 'Green shoots' for UK's biotech sector, Ligand buys XOMA and more from AstraZeneca, Novartis - FirstWord Pharma
FierceBiotech ٢٢ أبريل ٢٠٢٦ Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
FierceBiotech ١٥ أبريل ٢٠٢٦ Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen